Bush Vetoes Embryonic Stem Cell Bill
President Says Bill Would Support Taking Innocent Human Life, Override Fails
July 20, 2006 -- President Bush used the first veto of his presidency to reject a bill from Congress that would have expanded federally funded medical research using embryonic stem cells.
Bush's veto came less than a day after the Senate passed the bill 63-37. Despite the broadly bipartisan vote, the president said he remains opposed to research that would require the destruction of human embryos.
"This bill would support the taking of innocent human life in the hope of finding medical benefits for others. It crosses a moral boundary that our decent society needs to respect, so I vetoed it," Bush said, in a White House speech.
Bush has never wavered from his position finding it unacceptable to destroy embryos for medical studies. But his veto put him at odds with many pro-life lawmakers in his own party, who support the research because of its potential for creating cures for a host of diseases.
Some of the bill's supporters accused President Bush of holding back promising medical research because of his personal ideology.
Sen. Tom Harkin, (D-Iowa), said the veto was "a shameful act of cruelty and hypocrisy.
"With the stroke of a pen today, the president vetoed this bill and vetoed the hopes of millions of suffering Americans," said Harkin, one of the bill's sponsors.
The House voted 235-193 to override the veto, but that would have required 290 votes to succeed.
If enacted, the bill would have overturned a 2001 order by Bush that confined federal research funding to embryonic cell lines that had already been created. The new bill sought to expand funding to lines derived from embryos stored in fertilization clinics, as long as the embryos are scheduled for destruction and the donors consent to the research in writing.
States Fund Research
Only 21 of the original 77 lines qualifying under Bush's policy have proven healthy enough for research studies.
Several states, including Maryland and Massachusetts, have laws allowing and funding research on new embryonic cell lines. California has dedicated $3 billion to research on the cells.
Still, hundreds of patient and scientific groups argued that only federal funding and the backing of the National Institutes of Health could keep American labs at pace with efforts in Europe and elsewhere.